Eli Lilly and Co (NYSE:LLY)

106.88
Delayed Data
As of Sep 18
 +1.17 / +1.11%
Today’s Change
73.69
Today|||52-Week Range
107.84
+26.55%
Year-to-Date
Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern
Sep 18 / Zacks.com - Paid Partner Content
Allergan Frown Lines Study Passes Test on Higher Botox Dose
Sep 17 / Zacks.com - Paid Partner Content
Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?
Sep 18 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus
Sep 14 / Zacks.com - Paid Partner Content
Is Galapagos NV a Buy Now?
Sep 18 / MotleyFool.com - Paid Partner Content
AstraZeneca's Lumoxiti Gets FDA Nod for Hairy Cell Leukemia
Sep 14 / Zacks.com - Paid Partner Content
Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV
Sep 17 / Zacks.com - Paid Partner Content
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Sep 14 / Zacks.com - Paid Partner Content
Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval
Sep 17 / Zacks.com - Paid Partner Content
Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
Sep 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close105.71
Today’s open105.87
Day’s range105.11 - 107.19
Volume3,668,807
Average volume (3 months)3,594,402
Market cap$113.5B
Data as of 4:02pm ET, 09/18/2018

Growth & Valuation

Earnings growth (last year)-107.36%
Earnings growth (this year)+27.79%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+7.77%
P/E ratioNM
Price/Sales3.88
Price/Book10.03

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.21+0.48%
ABTAbbott Laboratories+0.74+1.09%
BMYBristol-Myers Squibb+0.18+0.29%
GSKGlaxoSmithKline+0.42+1.07%
Data as of 4:01pm ET, 09/18/2018

Financials

Next reporting dateOctober 23, 2018
EPS forecast (this quarter)$1.35
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts